The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
σ-1 Receptors (σ1 Binding Sites) Form Raft-Like Microdomains and Target Lipid Droplets on the Endoplasmic Reticulum: Roles in Endoplasmic Reticulum Lipid Compartmentalization and Export
Abstract
The brain sigma-1 receptors can bind neurosteroids and psychotropic drugs, including neuroleptics and cocaine and are implicated in schizophrenia, depression, and drug dependence. In this study, we found that sigma-1 receptors specifically target lipid storage sites (lipid droplets) on the endoplasmic reticulum by forming a distinct class of lipid microdomains. Both endogenously expressing sigma-1 receptors and transfected C-terminally enhanced yellow fluorescent protein (EYFP)-tagged sigma-1 receptors (Sig-1R-EYFP) target unique "ring-like" structures associated with endoplasmic reticulum reticular networks in NG108-15 cells. The ring-like structures contain neutral lipids and are enlarged by the oleate treatment, indicating that they are endoplasmic reticulum-associated lipid droplets (ER-LDs). sigma-1 receptors colocalize with caveolin-2, a cholesterol-binding protein in lipid rafts on the ER-LDs, but not with adipocyte differentiation-related protein (ADRP), a cytosolic lipid droplet (c-LD)-specific protein. When the double-arginine ER retention signal on the N terminus of sigma-1 receptors is truncated, sigma-1 receptors no longer exist on ER-LDs, but predominantly target c-LDs, which contain ADRP. sigma-1 receptors on ER-LDs form detergent-resistant raft-like lipid microdomains, the buoyancy of which is different from that of plasma membrane lipid rafts. (+)-Pentazocine causes sigma-1 receptors to disappear from the microdomains. N-Terminally EYFP-tagged sigma-1 receptors (EYFP-Sig-1R) failed to target ER-LDs. EYFP-Sig-1R-transfected cells showed an unrestricted distribution of neutral lipids all over the endoplasmic reticulum network, decreases in c-LDs and cholesterol in plasma membranes, and the bulbous aggregation of endoplasmic reticulum. Thus, sigma-1 receptors are unique endoplasmic reticulum proteins that regulate the compartmentalization of lipids on the endoplasmic reticulum and their export from the endoplasmic reticulum to plasma membrane and c-LDs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, SIGMAR1 appears to promote the compartmentalization of cholesterol in ER membranes (158), although depletion of cholesterol promoted mitochondrial–ER association in in vitro membrane association assays and cell models (159).”
From Adrenal Mitochondria and Steroidogenesis: From Individual Proteins to Functional Protein Assemblies (2016) · cites this paper as [158]
Citations
Cites
Lipid rafts and signal transduction
Simons, K., & Toomre, D. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35036052 · Cited by 5,371
Martin, W. R., Eades, C. G., Thompson, J. A., Huppler, R. E., & Gilbert, P. E. (1976) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30536-7 · Cited by 2,992
Anderson, R. G. W. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.199 · Cited by 1,941
Purification, molecular cloning, and expression of the mammalian sigma1-binding site.
Hanner, M., Moebius, F. F., Flandorfer, A., Knaus, H. G., Striessnig, J., Kempner, E. S., & Glossmann, H. H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.8072 · Cited by 914
Cholesterol metabolism in the brain
Dietschy, J. M., & Turley, S. D. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200104000-00003 · Cited by 906
The Surface of Lipid Droplets Is a Phospholipid Monolayer with a Unique Fatty Acid Composition
Tauchi-Sato, K., Ozeki, S., Houjou, T., Taguchi, R., & Fujimoto, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207712200 · Cited by 753
Brasaemle, D., Barber, T., Wolins, N. E., Serrero, G., Blanchette‐Mackie, E. J., & Londos, C. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34939-7 · Cited by 644
Mechanisms of lipid-body formation
Murphy, D. J., & Vance, J. E. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01349-8 · Cited by 577
Steroid Binding at σ Receptors Suggests a Link Between Endocrine, Nervous, and Immune Systems
Su, T., London, E. D., & Jaffe, J. H. (1988) · Science · doi:10.1126/science.2832949 · Cited by 548
Self-citationSu, T.-P. (1982) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33330-6 · Cited by 435
Self-citationThe Sigma Receptor as a Ligand-Regulated Auxiliary Potassium Channel Subunit
Aydar, E., Palmer, C. P., Klyachko, V. A., & Jackson, M. B. (2002) · Neuron · doi:10.1016/s0896-6273(02)00677-3 · Cited by 400
Regulating ankyrin dynamics: Roles of sigma-1 receptors
Hayashi, T., & Su, T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.491 · Cited by 351
Self-citationPol, A., Luetterforst, R., Lindsay, M. R., Heino, S., Ikonen, E., & Parton, R. G. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.5.1057 · Cited by 326
Brown, D., Lydon, J. P., McLaughlin, M. M., Stuart-Tilley, A. K., Tyszkowski, R., & Alper, S. L. (1996) · Histochemistry and Cell Biology · doi:10.1007/bf01463929 · Cited by 321
Schutze, M. P., Peterson, P. A., & Jackson, M. R. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06434.x · Cited by 313
Hayashi, T., Maurice, T., & Su, T. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39299-7 · Cited by 313
Self-citationHAYASHI, T., Maurice, T., & Su, T. (2000) · PubMed · Cited by 296
Self-citationBraverman, N., Lin, P., Moebius, F. F., Obie, C., Moser, A., Glossmann, H., Wilcox, W. R., Rimoin, D. L., Smith, M., Kratz, L., et al. (1999) · Nature Genetics · doi:10.1038/10357 · Cited by 285
Interactions of selective serotonin reuptake inhibitors with subtypes of σ receptors in rat brain
Narita, N., Hashimoto, K., Tomitaka, S.-I., & Minabe, Y. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00254-3 · Cited by 254
Ostermeyer, A. G., Paci, J. M., Zeng, Y., Lublin, D. M., Munro, S., & Brown, D. A. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.5.1071 · Cited by 253
On the Control of Lipolysis in Adipocytes
Londos, C., Brasaemle, D., Schultz, C. J., Adler‐Wailes, D. C., LEVIN, D. M., Kimmel, A. R., & Rondinone, C. M. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07794.x · Cited by 251
Caveolin-2 Is Targeted to Lipid Droplets, a New “Membrane Domain” in the Cell
Fujimoto, T., Kogo, H., Ishiguro, K., Tauchi-Sato, K., & Nomura, R. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.5.1079 · Cited by 250
N-methyl-D-aspartate-induced neuronal activation is selectively modulated by σ receptors
Monnet, F. P., Debonnel, G., Junien, J., & de Montigny, C. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90186-a · Cited by 233
Neuroprotective and anti-amnesic potentials of sigma (σ) receptor ligands
Maurice, T., & Lockhart, B. P. (1997) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(96)00160-1 · Cited by 211
Cocaine binding at σ receptors
Sharkey, J., Glen, K. A., Wolfe, S. A., & Kuhar, M. J. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90058-1 · Cited by 205
Cloning and Structural Analysis of the cDNA and the Gene Encoding the Murine Type 1 Sigma Receptor
Seth, P., Leibach, F. H., & Ganapathy, V. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7840 · Cited by 202
Urani, A., Roman, F. J., Phan, V. L., Su, T., & Maurice, T. (2001) · PubMed · Cited by 181
Self-citationMorin-Surun, M., Collin, T., Denavit-Saubié, M., Baulieu, E., & Monnet, F. (1999) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.96.14.8196 · Cited by 176
Sphingolipid transport in eukaryotic cells
Gerrit van, M. E. E. R., & Holthuis, J. C. M. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00054-8 · Cited by 157
Evidence for a multi-site model of the rat brain σ receptor
Bowen, W. D., Hellewell, S. B., & McGarry, K. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90200-8 · Cited by 143
Receptor mechanisms in antipsychotic drug action: focus on sigma receptors
Snyder, S. H., & Largent, B. L. (1989) · Journal of Neuropsychiatry · doi:10.1176/jnp.1.1.7 · Cited by 140
Takebayashi, M., Hayashi, T., & Su, T. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.041970 · Cited by 132
Self-citationUrani, A., Roman, F. J., Phan, V., Su, T., & Maurice, T. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29502-1 · Cited by 100
Self-citationσ Receptor antagonists block the development of sensitization to cocaine
Ujike, H., Kuroda, S., & Otsuki, S. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00693-1 · Cited by 96
McCann, D. J., & Su, T. (1990) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(90)90004-h · Cited by 74
Self-citationMatsumoto, R. R., McCracken, K. A., Pouw, B., Miller, J. M., Bowen, W. D., Williams, W. E., & de Costa, B. R. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00917-1 · Cited by 66
Yamamoto, H., Miura, R., Yamamoto, T., Shinohara, K., Watanabe, M., Okuyama, S., Nakazato, A., & Nukada, T. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00084-8 · Cited by 64
Nuwayhid, S. J., & Werling, L. L. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.043398 · Cited by 56
Cell Confluence-dependent Remodeling of Endothelial Membranes Mediated by Cholesterol
Corvera, S., DiBonaventura, C., & Shpetner, H. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001708200 · Cited by 55
Bouteiller, C. L., Jamme, M. F., David, M., Silve, S., Lanau, C., Dhers, C., Picard, C., Rahier, A., Taton, M., Loison, G., et al. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2560342.x · Cited by 41
Keon, J. P. R., James, C. S., Court, S., Baden-Daintree, C., Bailey, A. M., Burden, R. S., Bard, M., & Hargreaves, J. A. (1994) · Current Genetics · doi:10.1007/bf00351674 · Cited by 26
Flagged first, then by citations
Cited by
Sorted by citations
Hayashi, T., & Su, T.-P. (2007) · Cell · doi:10.1016/j.cell.2007.08.036 · Cited by 1,826
Self-citationMAM: more than just a housekeeper
Hayashi, T., Rizzuto, R., Hajnoczky, G., & Su, T.-P. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.12.002 · Cited by 787
Self-citationThe pharmacology of sigma-1 receptors.
Maurice, T., & Su, T.-P. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.07.001 · Cited by 654
Self-citationMillan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 569
The sigma-1 receptor chaperone as an inter-organelle signaling modulator
Su, T., Hayashi, T., Maurice, T., Buch, S. J., & Ruoho, A. E. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.08.007 · Cited by 466
Self-citation
Metadata
- Authors
- Hayashi, T., & Su, T.-P.
- Affiliations
- National Institutes of Health (US)
- ORCID
- Su, Tsung-Ping
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2003-08
- Volume
- 306
- Issue
- 2
- Pages
- 718-725
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2156975935
- Cited by
- 262
- References
- 41
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 6 · 2023: 14 · 2022: 5 · 2021: 25 · 2020: 13 · 2019: 9 · 2018: 6 · 2017: 13 · 2016: 12 · 2015: 12 · 2014: 18 · 2013: 11 · 2012: 12
- FWCI
- 3.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pharmacology and Experimental Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Caveolin-1 and cellular processes
- Keywords
- sigma-1 receptor, lipid rafts, lipid droplets, endoplasmic reticulum, caveolin-2, ADRP, pentazocine, neutral lipids, cholesterol, neurosteroids, NG108-15 cells
- MeSH terms
- Sigma-1 Receptor, Animals, Bacterial Proteins, Binding Sites, Endoplasmic Reticulum, Guinea Pigs, Hybridomas, Intracellular Membranes, Luminescent Proteins, Tumor Cells, Cultured, Protein Structure, Tertiary, Receptors, sigma, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review